Evidence map›Paper›PMID 23465048›Full record

ArticleChemical research in toxicology2013

Protein targets of thioacetamide metabolites in rat hepatocytes.

Yakov M Koen, Diganta Sarma, Heather Hajovsky, Nadezhda A Galeva, Todd D Williams, Jeffrey L Staudinger, Robert P Hanzlik

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Macrophage pathology in hepatotoxicity.Journal of toxicologic pathology · 2023
    Review
  4. Article
  5. Article
  6. Foods (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Indian journal of clinical biochemistry : IJCB · 2020
    Article
  12. Article
  13. Crystal structures of the naturally fused CS and cytochrome bActa crystallographica. Section D, Structural biology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Amelioration of thioacetamide-induced liver toxicity in Wistar rats by rutin.International journal of immunopathology and pharmacology · 2017
    Article
  18. Review
  19. Article
  20. Protective effects of pentoxifylline on acute liver injury induced by thioacetamide in rats.International journal of clinical and experimental pathology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yakov M KoenDepartment of Medicinal Chemistry, ‡Mass Spectrometry Laboratory, and §Department of Pharmacology & Toxicology, The University of Kansas , Lawrence, Kansas 66045, United States.
Diganta Sarma
Heather Hajovsky
Nadezhda A Galeva
Todd D Williams
Jeffrey L Staudinger
Robert P Hanzlik
University of Kansas · US

Funding

ROLE OF EPOXIDES IN METABOLISM AND DRUG TOXICITYR01GM021784 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 1985 to 2012
$2.9M
NIGMS NIH HHS GM-21784NIGMS NIH HHS R01 GM021784
6 · The paper itself

Abstract

Thioacetamide (TA) has long been known as a hepatotoxicant whose bioactivation requires S-oxidation to thioacetamide S-oxide (TASO) and then to the very reactive S,S-dioxide (TASO2). The latter can tautomerize to form acylating species capable of covalently modifying cellular nucleophiles including phosphatidylethanolamine (PE) lipids and protein lysine side chains. Isolated hepatocytes efficiently oxidize TA to TASO but experience little covalent binding or cytotoxicity because TA is a very potent inhibitor of the oxidation of TASO to TASO2. However, hepatocytes treated with TASO show extensive covalent binding to both lipids and proteins accompanied by extensive cytotoxicity. In this work, we treated rat hepatocytes with [(14)C]-TASO and submitted the mitochondrial, microsomal, and cytosolic fractions to 2DGE, which revealed a total of 321 radioactive protein spots. To facilitate the identification of target proteins and adducted peptides, we also treated cells with a mixture of TASO/[(13)C2D3]-TASO. Using a combination of 1DGE- and 2DGE-based proteomic approaches, we identified 187 modified peptides (174 acetylated, 50 acetimidoylated, and 37 in both forms) from a total of 88 nonredundant target proteins. Among the latter, 57 are also known targets of at least one other hepatotoxin. The formation of both amide- and amidine-type adducts to protein lysine side chains is in contrast to the exclusive formation of amidine-type adducts with PE phospholipids. Thiobenzamide (TB) undergoes the same two-step oxidative bioactivation as TA, and it also gives rise to both amide and amidine adducts on protein lysine side chains but only amidine adducts to PE lipids. Despite their similarity in functional group chemical reactivity, only 38 of 62 known TB target proteins are found among the 88 known targets of TASO. The potential roles of protein modification by TASO in triggering cytotoxicity are discussed in terms of enzyme inhibition, protein folding, and chaperone function, and the emerging role of protein acetylation in intracellular signaling and the regulation of biochemical pathways.

Indexed as

AnimalsCells, CulturedCytosolHepatocytesMaleMicrosomes, LiverMitochondria, LiverProteinsProteomicsRatsRats, Sprague-DawleyThioacetamideProteinsThioacetamidethioacetamide-S-oxide

Identifiers

PMID23465048
PMCPMC3710294
OpenAlexW1983905590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.